Yuval Cohen

Chief Executive Officer presso CORBUS PHARMACEUTICALS HOLDINGS, INC.

Patrimonio netto: 410 176 $ in data 31/03/2024

49 anni

Health Technology

Consumer Services

Profilo

Yuval Cohen is the founder of Celsus Therapeutics Plc, which was founded in 2005.
He held the title of Director & Senior Vice President at Celsus Therapeutics Plc in 2013.
Currently, Dr. Cohen is the Chief Executive Officer & Director at Corbus Pharmaceuticals, Inc. since 2013 and the Chief Executive Officer & Director at Corbus Pharmaceuticals Holdings, Inc. since 2014.
Dr. Cohen's education includes an undergraduate degree from the University of Cape Town and a doctorate degree from Université de Paris 5 René Descartes.

Partecipazioni note in società pubbliche

Società	Data	Numero di azioni	Valorizzazione	Data di valutazione
CORBUS PHARMACEUTICALS HOLDINGS INC 0.10%	22/03/2024	10 453 ( 0.10% )	410 176 $	31/03/2024

Posizioni attive di Yuval Cohen

Società	Posizione	Inizio
CORBUS PHARMACEUTICALS HOLDINGS, INC.	Chief Executive Officer	11/04/2014
Corbus Pharmaceuticals, Inc. Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA.	Chief Executive Officer	01/07/2013

Tutte le posizioni attive di Yuval Cohen

Precedenti posizioni note di Yuval Cohen

Società	Posizione	Fine
Celsus Therapeutics Plc Celsus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Celsus Therapeutics Plc is a drug development company, which focuses on developing novel, first-in-class, non-steroidal, synthetic anti-inflammatory drugs and multi-functional anti-inflammatory drugs. The company main clinical candidates are MRX-5, MRX-6, MRX-4, CFX-1 and OPX-1. Celsus Therapeutics was founded on October 7, 2004 and is headquartered in London, the United Kingdom.	Founder	01/12/2013

Vedi nel dettaglio l'esperienza di Yuval Cohen

Formazione di Yuval Cohen

University of Cape Town

Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Yuval Cohen

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
CORBUS PHARMACEUTICALS HOLDINGS, INC.	Health Technology

Aziende private	3
Celsus Therapeutics Plc Celsus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Celsus Therapeutics Plc is a drug development company, which focuses on developing novel, first-in-class, non-steroidal, synthetic anti-inflammatory drugs and multi-functional anti-inflammatory drugs. The company main clinical candidates are MRX-5, MRX-6, MRX-4, CFX-1 and OPX-1. Celsus Therapeutics was founded on October 7, 2004 and is headquartered in London, the United Kingdom.	Health Technology
Corbus Pharmaceuticals, Inc. Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA.	Health Technology
Université de Paris 5 René Descartes	Consumer Services

Vedi le connessioni aziendali